drugset / Trial / NCT01890902

Efficacy and Safety of Impracor (Ketoprofen 10% Cream) Compared With Placebo in the Treatment of Acute Pain (Flare) Associated With Osteoarthritis of the Knee

NCT01890902

Phase 3 Withdrawn Imprimis Pharmaceuticals, Inc.
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The primary objective of the study is to assess analgesic efficacy of Impracor (Ketoprofen 10% Cream) compared to placebo for acute pain associated with OA flare of the knee.

Timeline

Start
2013-08
Primary completion
2014-06
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject Ketoprofen Small molecule 10 % Topical

Indications

No indication recorded.